Home About Products & Services News Research Investors Contact


Neuronetics is focused on successfully developing and commercializing non-invasive therapies to treat chronic psychiatric and neurological disorders. We are committed to working collaboratively with the clinical community to improve care, at reasonable cost, for the many patients suffering from these disorders.

Neuronetics in the News

Health Watch: Magnetic Depression Therapy

Careers at Neuronetics

We're looking for talented, motivated professionals to join the Neuronetics team in key functional areas.

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.